advertisement

Topcon

Wu K 9

Showing records 1 to 9 | Display all abstracts from Wu K

105031 Identification of Nitric Oxide-Donating Ripasudil Derivatives with Intraocular Pressure Lowering and Retinal Ganglion Cell Protection Activities
Yang Z
Journal of Medicinal Chemistry 2022; 65: 11745-11758
104967 Systemic Barriers in Receiving Electronically Prescribed Glaucoma Medications
Oke I; Badami A
Journal of Glaucoma 2022; 31: 812-815
105031 Identification of Nitric Oxide-Donating Ripasudil Derivatives with Intraocular Pressure Lowering and Retinal Ganglion Cell Protection Activities
Wu J
Journal of Medicinal Chemistry 2022; 65: 11745-11758
104967 Systemic Barriers in Receiving Electronically Prescribed Glaucoma Medications
Kosteva KL
Journal of Glaucoma 2022; 31: 812-815
105031 Identification of Nitric Oxide-Donating Ripasudil Derivatives with Intraocular Pressure Lowering and Retinal Ganglion Cell Protection Activities
Wu K; Luo J
Journal of Medicinal Chemistry 2022; 65: 11745-11758
104967 Systemic Barriers in Receiving Electronically Prescribed Glaucoma Medications
Wu K
Journal of Glaucoma 2022; 31: 812-815
105031 Identification of Nitric Oxide-Donating Ripasudil Derivatives with Intraocular Pressure Lowering and Retinal Ganglion Cell Protection Activities
Li C
Journal of Medicinal Chemistry 2022; 65: 11745-11758
104967 Systemic Barriers in Receiving Electronically Prescribed Glaucoma Medications
Desai MA
Journal of Glaucoma 2022; 31: 812-815
105031 Identification of Nitric Oxide-Donating Ripasudil Derivatives with Intraocular Pressure Lowering and Retinal Ganglion Cell Protection Activities
Zhang J; Zhao M; Mei T; Liu X; Shang B; Zhang Y; Zhao L; Huang Z
Journal of Medicinal Chemistry 2022; 65: 11745-11758

Issue 23-2

Change Issue


advertisement

Topcon